Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
VHA Deploys Agentic AI Operating System to Improve Care Delivery
The new agentic AI system connects teams, automates workflows and accelerates decision-making across VA medical centers.
4m read -
NNSA Eyes Human-Machine Teaming to Boost Mission Efficiency
Officials say AI will reshape roles, enhance cybersecurity and support predictive maintenance as NNSA modernizes operations.
2m read -
White House Sets Sights on National AI Legislation by 2027
OSTP Director Michael Kratsios said the new AI framework sets stage for federal legislation and warned against fragmented state regulations.
2m read -
NASA Expands Nuclear, Workforce Strategies to Power Future Missions
NASA is advancing nuclear systems and workforce models to accelerate space exploration and mission readiness.
2m read
